The effect of amikacin and imipenem alone and in combination against an extended-spectrum β-lactamase–producing Klebsiella pneumoniae strain-Reference-Cited by-同舟云学术

The effect of amikacin and imipenem alone and in combination against an extended-spectrum β-lactamase–producing Klebsiella pneumoniae strain

Published:2007-05 Issue:1 Volume:58 Page:105-110
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Máthé András,Szabó Dóra,Anderlik Piroska,Rozgonyi Ferenc,Nagy Károly

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers;Adamis;Int. J. Antimicrob. Agents,2004

2. Assays for antimicrobial agents in body fluids;Anhalt,1985

3. Outcomes evaluation of patients with ESBL- and non–ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program;Bhavnani;Diagn. Microbiol. Infect. Dis.,2006

4. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae;Burgess;Diagn. Microbiol. Infect. Dis.,2004

5. Clinical and Laboratory Standards Institute (CLSI), (2005) Performance standards for antimicrobial susceptibility testing, 15th Information Supplement. Document M100-S15. Wayne (PA) 7.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models;Antimicrobial Agents and Chemotherapy;2024-03-06

2. Comparative Investigation into the Roles of Imipenem:Cyclodextrin Complexation and Antibiotic Combination in Combatting Antimicrobial Resistance in Gram-Negative Bacteria;Pharmaceuticals;2023-10-23

3. In Vitro and In Vivo Effect of Amikacin and Imipenem Combinations against Multidrug-Resistant E. coli;Tropical Medicine and Infectious Disease;2022-10-02

4. Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa;Antibiotics;2021-11-22

5. Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice;Hearing Research;2020-02